Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.
Mori M, Kovalenko L, Lyonnais S, Antaki D, Torbett BE, Botta M, Mirambeau G, Mély Y. Mori M, et al. Among authors: kovalenko l. Curr Top Microbiol Immunol. 2015;389:53-92. doi: 10.1007/82_2015_433. Curr Top Microbiol Immunol. 2015. PMID: 25749978 Free PMC article. Review.
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains.
Mori M, Kovalenko L, Malancona S, Saladini F, De Forni D, Pires M, Humbert N, Real E, Botzanowski T, Cianférani S, Giannini A, Dasso Lang MC, Cugia G, Poddesu B, Lori F, Zazzi M, Harper S, Summa V, Mely Y, Botta M. Mori M, et al. Among authors: kovalenko l. ACS Chem Biol. 2018 Jan 19;13(1):253-266. doi: 10.1021/acschembio.7b00907. Epub 2017 Dec 28. ACS Chem Biol. 2018. PMID: 29235845
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity.
Humbert N, Kovalenko L, Saladini F, Giannini A, Pires M, Botzanowski T, Cherenok S, Boudier C, Sharma KK, Real E, Zaporozhets OA, Cianférani S, Seguin-Devaux C, Poggialini F, Botta M, Zazzi M, Kalchenko VI, Mori M, Mély Y. Humbert N, et al. Among authors: kovalenko l. ACS Infect Dis. 2020 Apr 10;6(4):687-702. doi: 10.1021/acsinfecdis.9b00290. Epub 2020 Feb 21. ACS Infect Dis. 2020. PMID: 32045204
Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein.
Mori M, Dasso Lang MC, Saladini F, Palombi N, Kovalenko L, De Forni D, Poddesu B, Friggeri L, Giannini A, Malancona S, Summa V, Zazzi M, Mely Y, Botta M. Mori M, et al. Among authors: kovalenko l. ACS Med Chem Lett. 2018 Dec 7;10(4):463-468. doi: 10.1021/acsmedchemlett.8b00506. eCollection 2019 Apr 11. ACS Med Chem Lett. 2018. PMID: 30996780 Free PMC article.
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein.
Malancona S, Mori M, Fezzardi P, Santoriello M, Basta A, Nibbio M, Kovalenko L, Speziale R, Battista MR, Cellucci A, Gennari N, Monteagudo E, Di Marco A, Giannini A, Sharma R, Pires M, Real E, Zazzi M, Dasso Lang MC, De Forni D, Saladini F, Mely Y, Summa V, Harper S, Botta M. Malancona S, et al. Among authors: kovalenko l. ACS Med Chem Lett. 2020 Mar 19;11(5):766-772. doi: 10.1021/acsmedchemlett.9b00608. eCollection 2020 May 14. ACS Med Chem Lett. 2020. PMID: 32435383 Free PMC article.
New Hybrid Ethylenediurea (EDU) Derivatives and Their Phytoactivity.
Oshchepkov MS, Kovalenko LV, Kalistratova AV, Tkachenko SV, Gorunova ON, Bystrova NA, Kochetkov KA. Oshchepkov MS, et al. Among authors: kovalenko lv. Int J Mol Sci. 2024 Mar 15;25(6):3335. doi: 10.3390/ijms25063335. Int J Mol Sci. 2024. PMID: 38542308
Family case of Potocki-Lupski syndrome.
Kolbasin LN, Dubrovskaya TA, Salnikova GB, Solovieva EN, Donnikov MY, Illarionov RA, Glotov AS, Kovalenko LV, Belotserkovtseva LD. Kolbasin LN, et al. Among authors: kovalenko lv. Mol Cytogenet. 2024 Mar 22;17(1):6. doi: 10.1186/s13039-024-00673-5. Mol Cytogenet. 2024. PMID: 38519962 Free PMC article.
151 results